CROs/Service Providers

Biorasi adds endocrinology division, to hire 30

Thursday, February 12, 2015 01:02 PM

Biorasi, a full-service CRO powered by ProAct+, has formed an endocrinology division established to consolidate and expand Biorasi market leadership in running clinical trials in diabetes and women’s health. The new division will be led by Bill Doyle, the division manager, out of the Miami, Fla. headquarters.

More... »

Theorem Clinical Research

BioPharma Services, Scentryphar partner

Wednesday, February 11, 2015 12:30 PM

BioPharma Services (BPSI) has entered into a partnership and joint venture agreement with Scentryphar, a CRO located in Sao Paulo, Brazil. The partnership will support local and global sponsors looking to bring generic and innovative drugs to the Brazilian market by offering one-stop shopping and joint experience in clinical conduct, bioanalysis, data management, statistics and scientific and medical writing.

More... »

Quest Diagnostics

Water Street invests in generic injectable drug services company Custopharm

Wednesday, February 4, 2015 01:32 PM

Water Street Healthcare Partners, a strategic investor focused exclusively on the healthcare industry headquartered in Chicago, has invested in Custopharm, a generic injectable drug services company. Water Street's team has committed equity to both acquire and expand the Carlsbad, Calif.-based company. The healthcare firm has recruited William Larkins, Ph.D., former vice president and general manager of Bedford Laboratories, as CEO of Custopharm.

More... »

CSSi LifeSciences introduces SmartStudy Design and Feasibility

Wednesday, February 4, 2015 01:25 PM

CSSi LifeSciences, a Glen Burnie, Md.-based provider of fully integrated solutions that span the lifecycle of a new drug or device, has launched its newest product offering in its portfolio of services—SmartStudy Design and Feasibility. CSSi LifeSciences is a partner company of global patient recruitment solutions provider CSSi.

More... »

ChemPartner opens San Francisco research facility

Wednesday, February 4, 2015 01:22 PM

ChemPartner, the service division of the Shanghai, China-based ShangPharma group, recently expanded its global footprint with the establishment of a 24,000-square-foot research facility in South San Francisco.

More... »

Campbell Alliance forms suite of services for product launches

Monday, February 2, 2015 03:02 PM

Campbell Alliance, the consulting arm of inVentiv Health, has formed the Campbell Alliance Launch Suite, an integrated offering designed to bring products to market primed for success.

More... »

Icon to acquire MediMedia Pharma Solutions for $120M

Monday, February 2, 2015 01:54 PM

Icon, a global provider of outsourced development services to the pharmaceutical, biotechnology and medical device industries, has agreed, subject to certain customary closing conditions, to acquire MediMedia Pharma Solutions for a cash consideration of $120 million. MediMedia Pharma Solutions is division of MediMedia USA and is owned by Vestar Capital Partners.

More... »

Amerita acquires Infusionrx

Thursday, January 29, 2015 12:40 PM

Amerita, an Irvine, Calif.-based, wholly owned subsidiary of institutional pharmacy services company PharMerica, has completed the acquisition of Coastal Pharmaceutical Services company InfusionRx, based in Oxnard, Calif. Financial terms of the transaction have not been disclosed.

More... »

Icon creates new global innovation hub in Ireland to advance clinical development

Thursday, January 29, 2015 12:22 PM

Global CRO Icon has launched a new global innovation hub that will create 200 new jobs in Ireland.

More... »

WCCT, Stanford University laboratory to collaborate

Wednesday, January 28, 2015 12:09 PM

WCCT Global, a CRO headquartered in Southern California, has established a collaboration agreement with researchers in Dr. Garry P. Nolan's laboratory from the department of microbiology and immunology at Stanford University. Together with the National Institute of Allergy and Infectious Diseases (NIAID), WCCT Global currently is conducting influenza infection studies in healthy volunteers and is the first CRO to conduct such studies in North America.

More... »


March 2

Huntingdon Life Sciences-Harlan prepares for rebranding and U.S. expansion to compete with early phase CROs Covance, CRL

Patients' increased sharing of clinical trial experiences through social media can help sponsors improve outcomes, enrollment

Already a subscriber?
Log in to your digital subscription.

Subscribe to CWWeekly.

The CenterWatch Monthly


Novo Nordisk, Takeda, Servier, Celgene among top sponsors
New gains seen from patient- and site-centric initiatives

Patient reported outcomes take center stage
FDA combining PROs, clinical outcomes in its approval decisions

Already a subscriber?
Log in to your digital subscription.

Purchase the March issue.

Subscribe to
The CenterWatch Monthly.

The CenterWatch Monthly


Study grants market breaks $13 billion
Volume of clinical activity rising while growth in grant spending slows

Revisiting eClinical Technology Solutions Adoption
While use of established solutions grows, sponsors hesitate on newer tools

Already a subscriber?
Log in to your digital subscription.

Purchase the February issue.

Subscribe to
The CenterWatch Monthly.


Featured Jobs